Zydus Lifesciences Ltd
Q1 FY27, unaudited
- Revenue
- ₹2,872.20 Cr
- Profit after tax
- ₹339.60 Cr
As filed with the exchange, standalone basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Revenue from operations | 2,872.20 | +10.97% | 11,484.00 |
| Other income | 123.70 | −21.26% | 1,667.50 |
| Total income | 2,995.90 | +9.12% | 13,151.50 |
| Employee benefit expense | 561.40 | +15.23% | 1,966.20 |
| Finance costs | 103.10 | −25.07% | 482.90 |
| Depreciation & amortisation | 151.90 | +16.85% | 561.20 |
| Total expenses | 2,540.20 | +11.88% | 8,602.70 |
| Profit before tax | 455.70 | −4.04% | 4,381.90 |
| Tax expense | 116.10 | +28.71% | 822.10 |
| Profit after tax | 339.60 | −11.72% | 3,559.80 |
| Total comprehensive income | 360.60 | −6.51% | 3,588.50 |
| Earnings per share, basic | ₹3.38 | ₹35.38 |
|---|---|---|
| Earnings per share, diluted | ₹3.38 | ₹35.38 |
Earnings call
Q4 FY26Zydus Lifesciences reported consolidated revenue of ₹271.5 billion for FY26, up 17% year-on-year, with EBITDA margin at 31.2% and net profit adjusted for exceptional items at ₹54.6 billion, up 15%. Q4 FY26 revenue was ₹75.9 billion, up 16% year-on-year, with EBITDA margin of 33.7% and adjusted net profit of ₹15.9 billion. Management discussed growth across US formulations, India branded formulations, international markets, consumer wellness and medical devices, along with the proposed acquisition of Assertio Holdings and other pipeline updates.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary
Filings
12 shown · 104 published by the exchange
25 Aug 2026
Filing24 Aug 2026
23 Aug 2026
Presentation21 Aug 2026
Filing21 Aug 2026
18 Aug 2026
Transcript17 Aug 2026
12 Aug 2026
12 Aug 2026
Filing11 Aug 2026
FilingShareholder Meeting / Postal Ballot-Outcome of AGM
Appears 2 times in the recent filings shown; listed once.
11 Aug 2026
Filing11 Aug 2026
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 25 Aug 2026.